Tasca Therapeutics is a biotechnology research company based in Cambridge, Massachusetts, leveraging a unique platform to exploit lipid-binding pockets on proteins.
Subscribe to see Tasca Therapeutics Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tasca Therapeutics Corp is a biotechnology company headquartered in United States. Its most recent funding round, Series A, raised $67M in September 2025. Xcout tracks 21 named people at Tasca Therapeutics Corp, including Milenko Cicmil (President and CEO).
15 more named people on record for Tasca Therapeutics Corp, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $67M | 4 named | |
| SEC Form D filing | $24.1M | — | |
| Series A | $52M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Tasca Therapeutics Corp's closest competitors — see the full list of competitors and alternatives →
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Nabla Bio is a biotechnology company headquartered in Cambridge, Massachusetts. It develops protein engineering platforms and technical solutions.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Sculpta Bio is a biotechnology research company headquartered in San Francisco, California, known as the Protein Sculpting Company.
Triana Biomedicines, Inc. is a private biotechnology company focused on targeted molecular glue discovery. The company is headquartered in Lexington, Massachusetts.
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.